PainChek Limited
PainChek Limited (PCK.AX) Stock Competitors & Peer Comparison
See (PCK.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCK.AX | A$0.04 | +0.00% | 70M | -3.80 | -A$0.01 | N/A |
| PME.AX | A$319.77 | -1.06% | 33.4B | 340.18 | A$0.94 | +0.15% |
| VHT.AX | A$1.15 | +0.44% | 291.3M | -28.63 | -A$0.04 | N/A |
| CGS.AX | A$1.72 | -4.97% | 291.2M | 28.58 | A$0.06 | N/A |
| ONE.AX | A$0.25 | +0.00% | 189.5M | -8.33 | -A$0.03 | N/A |
| ALC.AX | A$0.12 | +0.00% | 161.2M | -12.00 | -A$0.01 | N/A |
| AYA.AX | A$1.05 | +5.00% | 119.6M | -5.83 | -A$0.18 | N/A |
| SHG.AX | A$0.32 | -3.08% | 95M | -15.75 | -A$0.02 | N/A |
| M7T.AX | A$0.39 | -3.70% | 91.6M | -19.50 | -A$0.02 | N/A |
| BMT.AX | A$0.27 | +0.00% | 77M | -13.25 | -A$0.02 | N/A |
Stock Comparison
PCK.AX vs PME.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, PME.AX has a market cap of 33.4B. Regarding current trading prices, PCK.AX is priced at A$0.04, while PME.AX trades at A$319.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas PME.AX's P/E ratio is 340.18. In terms of profitability, PCK.AX's ROE is -4.53%, compared to PME.AX's ROE of +0.48%. Regarding short-term risk, PCK.AX is less volatile compared to PME.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check PME.AX's competition here
PCK.AX vs VHT.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, VHT.AX has a market cap of 291.3M. Regarding current trading prices, PCK.AX is priced at A$0.04, while VHT.AX trades at A$1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas VHT.AX's P/E ratio is -28.63. In terms of profitability, PCK.AX's ROE is -4.53%, compared to VHT.AX's ROE of -0.18%. Regarding short-term risk, PCK.AX is less volatile compared to VHT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check VHT.AX's competition here
PCK.AX vs CGS.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, CGS.AX has a market cap of 291.2M. Regarding current trading prices, PCK.AX is priced at A$0.04, while CGS.AX trades at A$1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas CGS.AX's P/E ratio is 28.58. In terms of profitability, PCK.AX's ROE is -4.53%, compared to CGS.AX's ROE of +0.20%. Regarding short-term risk, PCK.AX is less volatile compared to CGS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check CGS.AX's competition here
PCK.AX vs ONE.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, ONE.AX has a market cap of 189.5M. Regarding current trading prices, PCK.AX is priced at A$0.04, while ONE.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas ONE.AX's P/E ratio is -8.33. In terms of profitability, PCK.AX's ROE is -4.53%, compared to ONE.AX's ROE of -1.17%. Regarding short-term risk, PCK.AX is less volatile compared to ONE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check ONE.AX's competition here
PCK.AX vs ALC.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, ALC.AX has a market cap of 161.2M. Regarding current trading prices, PCK.AX is priced at A$0.04, while ALC.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas ALC.AX's P/E ratio is -12.00. In terms of profitability, PCK.AX's ROE is -4.53%, compared to ALC.AX's ROE of -0.06%. Regarding short-term risk, PCK.AX is less volatile compared to ALC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check ALC.AX's competition here
PCK.AX vs AYA.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, AYA.AX has a market cap of 119.6M. Regarding current trading prices, PCK.AX is priced at A$0.04, while AYA.AX trades at A$1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas AYA.AX's P/E ratio is -5.83. In terms of profitability, PCK.AX's ROE is -4.53%, compared to AYA.AX's ROE of -0.92%. Regarding short-term risk, PCK.AX is less volatile compared to AYA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check AYA.AX's competition here
PCK.AX vs SHG.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, SHG.AX has a market cap of 95M. Regarding current trading prices, PCK.AX is priced at A$0.04, while SHG.AX trades at A$0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas SHG.AX's P/E ratio is -15.75. In terms of profitability, PCK.AX's ROE is -4.53%, compared to SHG.AX's ROE of -0.80%. Regarding short-term risk, PCK.AX is less volatile compared to SHG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check SHG.AX's competition here
PCK.AX vs M7T.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, M7T.AX has a market cap of 91.6M. Regarding current trading prices, PCK.AX is priced at A$0.04, while M7T.AX trades at A$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas M7T.AX's P/E ratio is -19.50. In terms of profitability, PCK.AX's ROE is -4.53%, compared to M7T.AX's ROE of -0.10%. Regarding short-term risk, PCK.AX is less volatile compared to M7T.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check M7T.AX's competition here
PCK.AX vs BMT.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, BMT.AX has a market cap of 77M. Regarding current trading prices, PCK.AX is priced at A$0.04, while BMT.AX trades at A$0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas BMT.AX's P/E ratio is -13.25. In terms of profitability, PCK.AX's ROE is -4.53%, compared to BMT.AX's ROE of -0.12%. Regarding short-term risk, PCK.AX is less volatile compared to BMT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check BMT.AX's competition here
PCK.AX vs MDR.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, MDR.AX has a market cap of 49.4M. Regarding current trading prices, PCK.AX is priced at A$0.04, while MDR.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas MDR.AX's P/E ratio is -7.90. In terms of profitability, PCK.AX's ROE is -4.53%, compared to MDR.AX's ROE of -0.09%. Regarding short-term risk, PCK.AX is less volatile compared to MDR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check MDR.AX's competition here
PCK.AX vs DOC.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, DOC.AX has a market cap of 47.7M. Regarding current trading prices, PCK.AX is priced at A$0.04, while DOC.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas DOC.AX's P/E ratio is -4.33. In terms of profitability, PCK.AX's ROE is -4.53%, compared to DOC.AX's ROE of -5.56%. Regarding short-term risk, PCK.AX is less volatile compared to DOC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check DOC.AX's competition here
PCK.AX vs EMD.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, EMD.AX has a market cap of 28.1M. Regarding current trading prices, PCK.AX is priced at A$0.04, while EMD.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas EMD.AX's P/E ratio is -1.53. In terms of profitability, PCK.AX's ROE is -4.53%, compared to EMD.AX's ROE of -0.56%. Regarding short-term risk, PCK.AX is less volatile compared to EMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check EMD.AX's competition here
PCK.AX vs COO.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, COO.AX has a market cap of 26.3M. Regarding current trading prices, PCK.AX is priced at A$0.04, while COO.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas COO.AX's P/E ratio is N/A. In terms of profitability, PCK.AX's ROE is -4.53%, compared to COO.AX's ROE of -0.05%. Regarding short-term risk, PCK.AX and COO.AX have similar daily volatility (0.00).Check COO.AX's competition here
PCK.AX vs RHT.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, RHT.AX has a market cap of 18.4M. Regarding current trading prices, PCK.AX is priced at A$0.04, while RHT.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas RHT.AX's P/E ratio is N/A. In terms of profitability, PCK.AX's ROE is -4.53%, compared to RHT.AX's ROE of -0.03%. Regarding short-term risk, PCK.AX and RHT.AX have similar daily volatility (0.00).Check RHT.AX's competition here
PCK.AX vs IME.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, IME.AX has a market cap of 17.7M. Regarding current trading prices, PCK.AX is priced at A$0.04, while IME.AX trades at A$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas IME.AX's P/E ratio is -5.50. In terms of profitability, PCK.AX's ROE is -4.53%, compared to IME.AX's ROE of -0.18%. Regarding short-term risk, PCK.AX and IME.AX have similar daily volatility (0.00).Check IME.AX's competition here
PCK.AX vs 1ST.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, 1ST.AX has a market cap of 15.6M. Regarding current trading prices, PCK.AX is priced at A$0.04, while 1ST.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas 1ST.AX's P/E ratio is -1.10. In terms of profitability, PCK.AX's ROE is -4.53%, compared to 1ST.AX's ROE of +0.69%. Regarding short-term risk, PCK.AX and 1ST.AX have similar daily volatility (0.00).Check 1ST.AX's competition here
PCK.AX vs HIQ.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, HIQ.AX has a market cap of 9.4M. Regarding current trading prices, PCK.AX is priced at A$0.04, while HIQ.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas HIQ.AX's P/E ratio is -1.90. In terms of profitability, PCK.AX's ROE is -4.53%, compared to HIQ.AX's ROE of +2.49%. Regarding short-term risk, PCK.AX and HIQ.AX have similar daily volatility (0.00).Check HIQ.AX's competition here
PCK.AX vs ICR.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, ICR.AX has a market cap of 6.3M. Regarding current trading prices, PCK.AX is priced at A$0.04, while ICR.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas ICR.AX's P/E ratio is -1.30. In terms of profitability, PCK.AX's ROE is -4.53%, compared to ICR.AX's ROE of -10.86%. Regarding short-term risk, PCK.AX and ICR.AX have similar daily volatility (0.00).Check ICR.AX's competition here
PCK.AX vs OPL.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, OPL.AX has a market cap of 5.2M. Regarding current trading prices, PCK.AX is priced at A$0.04, while OPL.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas OPL.AX's P/E ratio is -2.10. In terms of profitability, PCK.AX's ROE is -4.53%, compared to OPL.AX's ROE of +12.65%. Regarding short-term risk, PCK.AX and OPL.AX have similar daily volatility (0.00).Check OPL.AX's competition here
PCK.AX vs MEB.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, MEB.AX has a market cap of 4.5M. Regarding current trading prices, PCK.AX is priced at A$0.04, while MEB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas MEB.AX's P/E ratio is -0.10. In terms of profitability, PCK.AX's ROE is -4.53%, compared to MEB.AX's ROE of -0.47%. Regarding short-term risk, PCK.AX is less volatile compared to MEB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check MEB.AX's competition here
PCK.AX vs GLH.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, GLH.AX has a market cap of 4.4M. Regarding current trading prices, PCK.AX is priced at A$0.04, while GLH.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas GLH.AX's P/E ratio is -7.50. In terms of profitability, PCK.AX's ROE is -4.53%, compared to GLH.AX's ROE of +0.27%. Regarding short-term risk, PCK.AX is less volatile compared to GLH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PCK.AX.Check GLH.AX's competition here
PCK.AX vs TD1.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, TD1.AX has a market cap of 4.2M. Regarding current trading prices, PCK.AX is priced at A$0.04, while TD1.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas TD1.AX's P/E ratio is -0.10. In terms of profitability, PCK.AX's ROE is -4.53%, compared to TD1.AX's ROE of -0.24%. Regarding short-term risk, PCK.AX and TD1.AX have similar daily volatility (0.00).Check TD1.AX's competition here
PCK.AX vs CTQ.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, CTQ.AX has a market cap of 2.8M. Regarding current trading prices, PCK.AX is priced at A$0.04, while CTQ.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas CTQ.AX's P/E ratio is -1.20. In terms of profitability, PCK.AX's ROE is -4.53%, compared to CTQ.AX's ROE of -0.62%. Regarding short-term risk, PCK.AX and CTQ.AX have similar daily volatility (0.00).Check CTQ.AX's competition here
PCK.AX vs OAK.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, OAK.AX has a market cap of 1.8M. Regarding current trading prices, PCK.AX is priced at A$0.04, while OAK.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas OAK.AX's P/E ratio is -1.67. In terms of profitability, PCK.AX's ROE is -4.53%, compared to OAK.AX's ROE of -0.44%. Regarding short-term risk, PCK.AX and OAK.AX have similar daily volatility (0.00).Check OAK.AX's competition here
PCK.AX vs JTL.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, JTL.AX has a market cap of 281.3K. Regarding current trading prices, PCK.AX is priced at A$0.04, while JTL.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas JTL.AX's P/E ratio is -0.10. In terms of profitability, PCK.AX's ROE is -4.53%, compared to JTL.AX's ROE of +0.60%. Regarding short-term risk, PCK.AX and JTL.AX have similar daily volatility (0.00).Check JTL.AX's competition here
PCK.AX vs TTB.AX Comparison July 2025
PCK.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCK.AX stands at 70M. In comparison, TTB.AX has a market cap of 267.4K. Regarding current trading prices, PCK.AX is priced at A$0.04, while TTB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCK.AX currently has a P/E ratio of -3.80, whereas TTB.AX's P/E ratio is -0.02. In terms of profitability, PCK.AX's ROE is -4.53%, compared to TTB.AX's ROE of -1.05%. Regarding short-term risk, PCK.AX and TTB.AX have similar daily volatility (0.00).Check TTB.AX's competition here